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Abstract
Background: Implementation of cotrimoxazole prophylaxis (CTX-p) among HIV-exposed infants (HEI) is poor in
southern Africa. We conducted a study to investigate barriers to delivery of CTX-p to HEI in Zimbabwe at each step
of the care cascade. Here we report findings of the qualitative component designed to investigate issues related to
adherence conducted among women identified as HIV positive whose babies were started on CTX-p postnatally.
Of note, Zimbabwe also provided nevirapine prophylaxis for HIV exposed babies, so the majority were giving nevirapine
and CTX-p to their babies.
Methods: Between Feb–Dec 2011, the first 20 HIV infected mothers identified were invited for in-depth
interview 4–5months postnatally. Interviews were recorded, transcribed, translated and analysed thematically.
Results: All women desired their baby’s health above all else, and were determined to do all they could to
ensure their wellbeing. They did not report problems remembering to give drugs. The baby’s apparent good
health was a huge motivator for continued adherence. However, most women reported that their husbands
were less engaged in HIV care, refusing to be HIV tested and in some cases stealing drugs prescribed for their wives for
themselves. In two instances the man stopped the woman from giving CTX-p to the baby either because of
fear of side effects or not appreciating its importance. Stigma continues to be an important issue. Mothers
reported being reluctant to disclose their HIV status to other people so found it difficult to collect prescription refills
from the HIV clinic for fear of being seen by friends/relatives. Some women reported that it was hard to administer the
drugs if there were people around at home. Other challenges faced were stock-outs of CTX-p at the clinic,
which occurred three times in 2011. The baby would then go without CTX-p if the woman could not afford
buying at a private pharmacy.
Conclusions: The study highlights that adherence knowledge and desire alone is insufficient to overcome the familial
and structural barriers to maintaining CTX-p. Improving adherence to CTX-p among HEI will require interventions to
improve male involvement, reduce HIV stigma in communities and ensure adequate supply of drugs.
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Background
Infants born to HIV infected mothers (HIV-exposed in-
fants, HEI) are at risk of mother-to-child transmission of
HIV during pregnancy, delivery and breastfeeding. There
is also evidence that HEI suffer more morbidity and
mortality than infants born to HIV negative mothers
likely due to 1) greater exposure to infection agents, 2)
poor nutrition and care as a result of the mother’s illness
or death [1–3]; and 3) altered innate immunity which
could be mediated by exposure to HIV in utero and
early in life or exposure to maternal antiretroviral drugs
during prevention of mother to child transmission
(PMTCT) [4, 5]. Many interventions have been intro-
duced to prevent mother-to-child transmission of HIV
and/or opportunistic infections among both HIV-infected
and uninfected HEI. These include ARV prophylaxis and/
or treatment regimens for the mother and infant that are
given for various lengths of time depending on the infant
feeding method and the WHO guideline that the PMTCT
programme has adopted. Those programmes adopting
Option B/B+ guidelines advise HEI to take ARV prophy-
laxis for the first 4–6 weeks of life, but those adopting Op-
tion A recommend that infants continue on nevirapine
prophylaxis until one week after cessation of breastfeeding
[6, 7]. In addition, all HEI in generalised HIV epidemics
should take cotrimoxazole prophylaxis (CTX-p) from the
first 4–6 weeks of life and continue until HIV infection
can be excluded [8]. This means mothers and carers need
to devote attention and care in ensuring adherence to
these life-saving pharmacological interventions.
Unfortunately, current literature shows an unaccept-
able loss to follow up of infants along the PMTCT cas-
cade [9, 10]. A recent systematic review estimated that
34 % of infants in Sub-Saharan Africa are lost to follow
up from real-life PMTCT programs by three months of
age, and 45 % are lost after HIV testing [11]. In
Zimbabwe, retention of HEI has been a challenge since
inception of PMTCT services. In 2007, only 11 % of in-
fants who needed CTX-p received it [12] increasing to
34 % in 2010 [13] and 55 % in 2012 [14]. Studies have
been done to explore barriers to retention of HEI along
the PMTCT cascade from the carer’s perspective [15–17],
and these include intrapersonal barriers such as fear that
the infant will test HIV positive, spiritual and traditional
beliefs, disbelief that PMTCT interventions work, time
and money constraints and fear of disclosure of HIV
status; interpersonal and community e.g. unsupportive
male partners, stigmatising attitudes from family and
community; health care system e.g. unfriendly health
care workers, long queues and waiting times and differ-
ent appointments for mothers and infants. However,
there is a dearth of literature on barriers and facilitators
to adherence to pharmaceutical interventions among
HEI who are retained in regular follow-up.
As part of a wider study that investigated barriers at
various steps of the PMTCT cascade, we conducted a
qualitative study to explore women’s ability to maintain
their babies on CTX-p after they had been initiated at
age six weeks. Although this study focused on CTX-p,
the findings and implications do not relate to the issue
of CTX-p provision alone but to the whole package of
services provided to HIV-exposed infants along the
PMTCT cascade.
Methods
The study was conducted at Mbare Clinic, Harare, during
the period when the country was implementing WHO
Option A (Zimbabwe transitioned to option B+ between
2013 and 2014). Between February to December 2011,
we consecutively enrolled twenty willing women (who
gave informed consent) and individually interviewed
them in-depth. Eligible women were HIV positive and
had babies who been started on CTX-p at age six
weeks. In addition to CTX-p most babies were also be-
ing prescribed nevirapine prophylaxis (babies whose
mothers were on ARVs for their own health were not
prescribed nevirapine prophylaxis after six weeks of
age). To identify HIV positive women, a cross-sectional
survey was conducted during the antenatal period. A
female study nurse conducted the survey and a fe-
male pharmacist who had been trained in social sci-
ence methods conducted the in-depth interviews.
Both study staff were external to the clinic system
(i.e. they were not employed at the clinic and partici-
pants understood this).
Interviews were held in private at the clinic when the
baby was 4–5 months old. Women were interviewed in
their local language according to an interview guide
which explored perception of their HIV status, views on
importance of CTX-p, and barriers and facilitators to
medication adherence. Table 1 shows the key areas of in-
vestigation. Given the sensitive nature of discussions on
HIV, in-depth interviews were the method of choice be-
cause they allow exploration of participant experiences
or social contexts in private. Participants were assured
that researchers would handle all data with confidential-
ity; interview records were identified using codes/num-
bers instead of names.
Interviews were completed in 30—45 min. All were
digitally recorded, transcribed, translated and analysed ac-
cording to thematic analysis. Data analysis commenced as
soon as data collection began: after each interview field
notes were written with a view to identifying emerging
themes. Following transcription and translation, analytic
summaries were written for each interview using an
approach which compared themes across participants,
thus identifying similarities and deviant cases. A cod-
ing framework was developed and used for coding all
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the interviews. Coding was done by one researcher.
Data handling and analysis was done using NVIVO
10 (qualitative data management software). In writing
the report, thematic findings were illustrated using
verbatim quotes which were selected on the basis of
being representative of the quotes that related to a
specific theme.
Ethical considerations
The study had ethical approval from Medical Research
Council of Zimbabwe and University College London
Research Ethics Committee. Written informed consent
was obtained from all participants before interviews
were conducted.
Results
Description of participants
Out of 35 HIV positive women who were identified during
the cross-sectional survey, 20 agreed to regular follow-up
(and were interviewed at 4–5 months for this qualitative
study); four were lost to follow-up before the 4–5 month
period and 11 refused participation. Most refusers said they
had no time. Non-participants did not differ from partici-
pants in terms of demographic characteristics.
To give an idea of the characteristics of the 20 inter-
viewed participants: most (16) were married and major-
ity were multiparous (Table 2). Thirteen were diagnosed
with HIV during their most recent pregnancy, four in
previous pregnancies and three had been diagnosed as a
result of theirs or their children’s illness. All came from
poor families; they either had no own income or earned
very little from self-employment. The women lived in
crowded accommodation where it was common to find
several people (or more than one family) residing in a
single room.
Barriers and facilitators to CTX-p adherence
Factors affecting women’s ability to keep their babies on
CTX-p were grouped into 1) participant-level, 2) personal
and community relationship level, and 3) health care sys-
tem factors.
Participant knowledge, attitudes and beliefs
Desire for baby’s health
In all interviews, it was clear that women were anxious
about how their HIV infection might affect their babies’
health; they reported being determined to do their best
to ensure the baby’s wellbeing. They understood the im-
portance of CTX-p for the baby’s health and reported
that they never forgot to administer the drug.
It causes you to constantly be alert; this is a baby I
love, it’s a life…since the nurses who have the experience
said it works so I have to make it possible. 24-year old
married mother of two
Perceived health benefit
The perceived benefits of CTX-p encouraged women to
keep giving it. During interviews they marvelled at how
much healthier their babies were compared to other
children in the community or their older children who
had not been on CTX-p.
I have noticed that giving cotrimoxazole to the baby
is helpful. If you keep giving it he does not suffer
from colds, or diarrhoea like what other children
do. 27-year old married mother of four
Cotrimoxazole is important because in the community I
live there are some children who are not on medication,
as I speak right now they have been to hospital a
countless number of times. But with this child I
have not been to hospital since delivery. 35 year
old, married mother of four
Having a baby test HIV negative at six weeks was re-
ported to provide encouragement and further impetus to
keep giving cotrimoxazole and nevirapine, likely because
Table 1 Key areas of investigation during in-depth interviews
Key areas of investigation Specific probes
Background information Area of residence, marital status, family environment
Current health status Physical strength and well-being following delivery
Feelings about HIV infection History of HIV testing; feelings about HIV positive diagnosis
HIV care for the participant (mother) What HIV care has been sought
Views of risk of mother-to-child transmission of HIV Awareness/knowledge of risks; feelings about ability to protect the baby from infection
Views on cotrimoxazole prophylaxis Knowledge/awareness of the importance of cotrimoxazole prophylaxis; views on CTX-p
Experience giving CTX-p to the baby Barriers and facilitators to daily administration, including experience with prescription refills
at the clinic
Awareness of other PMTCT services that baby is supposed to get Probes on awareness
Any related issues that participant wanted to raise
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of increased confidence in the health care interventions
that were offered at the clinic.
When I was given her HIV (negative) test results that’s
when I became more convinced that it is important to
adhere to the given instructions. 24 year old married
mother of two
Unfortunately, the converse was also true; perceived
ineffectiveness of PMTCT interventions was associ-
ated with poor adherence. One woman stopped giving
CTX-p when her baby tested HIV positive because
she felt let down by the pharmaceutical interventions.
Aids to remembering
Because adherence was important to them, women re-
ported that they used reminders to ensure that they did
not forget. Most used phone alarms as aids to remem-
bering. As many had already established routines for tak-
ing their own medicines (ARVs and CTX-p) they found
it easy to fit the babies into these routines.
Acceptance of HIV results
All participants reported that they were devastated when
they themselves tested HIV positive; two said they had
contemplated suicide. Most had initially interpreted the
diagnosis as warning of imminent death and some had
not known that it was possible to give birth to an HIV
negative baby.
…I thought, is this really my status? Does this really
mean I am about to die? All my thoughts were about
death. 24 year old married mother of two
Fortunately, most participants reported that their
initial fears were replaced by more positive thoughts
following support, counselling and education from
family and health care workers, as described below.
Three women did not get this support and had not
come to terms with their HIV status by the time of
the interview. There was evidence that those women
who had not come to terms with their status reported
adherence challenges, e.g. not collecting prescription
refills on time and not giving medicine when they
were feeling depressed.
I am putting effort to block it out of my mind. I heard
some people say if you think about it too much, he-e-e
your mind…you will get stressed and you will die
quickly. So I pretend it doesn’t matter and ignore
it… 29-year old divorced mother of three, sometimes
didn’t collect prescription refills
Table 2 Characteristics of interviewed participants
Participant Age (Years) Marital Status No of children Timing of HIV diagnosis Occupation
1 30 Married 4 During ANCa, at 3 months Sells vegetables
2 23 Married 2 During ANC Not employed
3 35 Married 3 During ANC, at 6 months Sells vegetables
4 36 Married 2 Previous pregnancy, 2009 Not employed
5 33 Married 3 During ANC, at 9 months Sells vegetables
6 33 Married 2 Previous pregnancy, 2003 Not employed
7 37 Married 4 During ANC, at 6 months Sells vegetables
8 27 Married 3 During ANC, at 8 months Not employed
9 41 Divorced 5 2005 when she was sick Meat vending
10 19 Single 1 During ANC, at 6 months Not employed
11 35 Married 3 During ANC, at 7 months Not employed
12 23 Married 1 Previous pregnancy, 2009 Not employed
13 24 Married 2 VCTb, March 2010 Not employed
14 24 Married 3 During ANC, at 8 months Meat vending
15 29 Divorced 3 Tested at delivery Dancer
16 33 Widow 5 During ANC, at 8 months General vending
17 27 Married 4 2008, child was sick Sells vegetables
18 23 Married 1 During ANC, at 6 months General vending
19 32 Married 2 2007, when she was sick Sex work
20 35 Married 4 Previous pregnancy, 2008 Sells vegetables
aANC, Antenatal care
bVCT, Voluntary Counselling and Testing
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Personal and community relationships
Personal and community relationships had a direct im-
pact on adherence and were also important for accept-
ance of HIV status (which itself was associated with
good adherence).
Relations with husbands/partners
Analysis of women’s accounts revealed that husbands/
partners (16 participants were married) had a make-or-
break influence on adherence. When looking at patterns
in the women’s responses on level of adherence support
they received from their husbands, it was clear that the
less engaged in HIV issues a husband was, the less sup-
portive for CTX-p. Three groups of husbands/partners
were identified: 1) six men who provided the most sup-
port for adherence, 2) five who were not opposed to
CTX-p but did not actively support it, and 3) five who
opposed CTX-p.
Out of the 16 married women, only six had husbands
who were positively supportive of CTX-p. The main fac-
tor that distinguished these men was that they had been
for couples testing and counselling together with their
wives. Two were HIV negative, and the others were ei-
ther already on ART or in regular monitoring for ART
eligibility. These men supported adherence in many
ways. First, they provided support to their wives during
the difficult period soon after HIV diagnosis which
helped the women accept their HIV status which was
apparently important for adherence.
With time I accepted it (her HIV status) because when
I told him he received it well and we went for couples
testing and he accepted it. 23 year old mother of one
I was expecting that he would start shouting at me,
saying how come you have the disease, where did you
get it from? But he was the one to say ahh it is possible
to get a situation where the man has no disease and
the woman has it…So because he did not get angry the
situation did not become too difficult for me; because
my husband showed me love, and said let’s remain
together. Married mother of four, HIV sero-discordant
relationship
This group of men also took an active part in ensuring
that the baby was given CTX-p, e.g. by reminding the
woman to give it and buying it from private pharmacies
when the clinic had no supplies.
The second group consists of five men who had taken
small steps towards confronting HIV in the family. All
initially had negative reactions when the women dis-
closed their HIV results but with time they came to a
point where they could discuss their family’s HIV care;
they accepted the wife’s HIV status and were not
opposed to the baby taking CTX-p, although they did
not actively support it. Their main challenge was that
they were not ready to share their own HIV status with
their wives. All of them refused to go for couples coun-
selling and testing and were sometimes hostile when this
was suggested. There was the suggestion that the re-
sponse to HIV was shaped by relationship dynamics
and gender norms; it seemed that men were more
accepting of their partner’s HIV status than the women
expected. When explaining why her husband did not
want to test for HIV, one participant said “He is afraid
that if he tests positive I might leave him,” which is a
paradox given that he had not left her when he discov-
ered that she had HIV.
The least supportive group consisted of five husbands
who were opposed to CTX-p. They reportedly did not
want any reference to HIV in the family. When their
wives told them their results they refused to accept them
and refused to understand the reasons why the baby had
to be on cotrimoxazole; one feared that cotrimoxazole
had harmful side effects. Three of the husbands forced
their wives to stop giving CTX-p.
I explained that the cotrimoxazole is for prevention of
infections. And he said ha-a my child is not going to
keep taking medicines willy-nilly. 23-year old married
mother of two
One participant tried to keep giving the CTX-p in
secret but when her husband discovered it “He said if I
kept giving cotrimoxazole he would take the baby away
from me and give him to his mother.”
Thirteen women were in regular HIV care for their own
health, and were taking CTX-p. Two of the seven women
who were not in regular HIV care reported that they were
stopped from taking their cotrimoxazole by their husbands,
while ironically two men reportedly stole the CTX-p that
had been prescribed for their wives for themselves.
About a month after I delivered he suddenly asked me
what the tablets (cotrimoxazole) were for. I explained
to him and he became angry and said, “This is madness,
these are all lies.” Then he took the tablets and threw
them away.” 23-year old married mother of two
Relationships in the community: fear of HIV disclosure
The community was reported as not having good under-
standing of HIV, and did not have a positive attitude to-
wards HIV positive people, who were often laughed at
or ridiculed. Women were therefore keen to prevent un-
wanted HIV disclosure, sometimes even to people who
lived in the same crowded room, in order to avoid
stigma. This made it difficult to give medicine at home.
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“The challenge is people can come before I have given
the medicine; then I will take the bottle outside… I can
actually go and give the medicine in the toilet”. 23-year
old married mother of one
This was particularly a challenge because of the un-
hygienic state of the shared toilets.
The same fear of stigma also made it difficult to collect
prescription refills at the clinic. Although all chronic dis-
ease patients collected their medicines from this clinic,
the community viewed it as an HIV clinic which made it
difficult for some women to go there.
Sometimes it’s hard for me to collect the medicine because
I might see someone I know; then it becomes incredibly
difficult because I have not disclosed to anyone except my
husband. 23-year old married mother of one
Health system factors
Counselling and education
The education and counselling that health care workers
gave soon after HIV diagnosis was reported to be helpful in
allaying fears and helping women accept their HIV status.
She (the counsellor) helped me to accept it…she told
me that I can give birth to a normal baby who can
grow up without HIV. 23 year old mother of one
Of note, none of the women reported that they got
this support/education from health care workers at the
clinic, but they had either visited other centres or been
counselled/educated by the study nurse.
Health system barriers to adherence included drug
stock-outs and long queues at the clinic.
Drug stock-outs
The wider study in which this qualitative work was
nested found that paediatric cotrimoxazole went out of
stock three times in the course of 2011; in two instances
it was out for almost three weeks. Nine of the twenty
women reported having been affected by the stock-outs,
which meant they had to buy from private pharmacies.
Babies whose mothers could not afford buying went
without medicine. Related to this, several participants re-
ported that they sometimes had insufficient cotrimoxa-
zole prescribed to last until their next appointment;
many said they would get 100mls (40 days’ supply) yet
the date of the next appointment was two months away,
thereby forcing poor adherence practices.
I stopped giving cotrimoxazole at that time. I could
not give it as directed because I wanted it to last until
the next appointment date. 41 year old divorced
mother of five
Long queues at the clinic
Long queues/waiting times at the clinic also posed chal-
lenges to women. Participants reported that they typic-
ally had to dedicate the whole day to a clinic visit, which
they found difficult.
We just know that a clinic appointment means that
you will spend the whole day at the clinic; you will
not even have time to wash the baby’s nappies.
41 year old married mother of 5
Related to this, women were scheduled to attend the
clinic at different times for their own HIV care, which
meant spending more days at the clinic.
Discussion
The study revealed that adherence to CTX-p among
HEI is influenced by the mother’s knowledge, attitudes
and beliefs including perception of the importance and
effectiveness of the intervention, desire for the baby’s
health and acceptance of HIV status. Husbands were re-
ported to have an important role, and the fear of HIV
disclosure and subsequent stigma limited women’s abil-
ity to freely give CTX-p at home or to collect prescrip-
tion refills. Health system factors such as provision of
education and counselling and availability of drugs were
important determinants of adherence. A significant
strength of this study was the trust that participants
had in the researcher/interviewer, whom they under-
stood to be a health care worker who had a lot of infor-
mation on HIV. As a result they openly discussed
intimate details about their lives in the way they would
with a trusted health care worker, sometimes in an ef-
fort to get more assistance/guidance on what services
to seek for themselves or their babies and sometimes as
to vent their feelings (in some instances the study team
were the first people that the women had an in-depth
discussion about their HIV infection with). The fact the
interviewer was known to be external to the system at
the clinic helped participants feel able to openly discuss
challenges they faced with the clinic. This allowed a
clearer insight into the participant’s situations. Although
this study focused on CTX-p, the findings can be general-
ised to other pharmaceutical PMTCT interventions.
As expected, awareness of the rationale for giving
CTX-p was associated with good adherence, which un-
derlies the importance of educating mothers and carers
about CTX-p/PMTCT interventions that have been pre-
scribed. Perception of effectiveness is an important fac-
tor that motivated mothers: where the intervention was
perceived to be ineffective, poor adherence ensued as
was seen when one woman lost faith in all pharmaceut-
ical interventions after her baby tested HIV positive.
Clearly she had not properly understood the different
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roles of nevirapine and CTX-p and did not adequately
appreciate the concept of risk reduction (as compared to
risk cessation). It is likely important that women are
given a more nuanced understanding of the likely effect-
iveness of nevirapine and CTX-p to ensure ongoing
compliance in the event of transmission events. In the
event of transmission, health care workers need to revisit
this and also counsel about the importance of ongoing
prophylactic treatment.
The extent of male partner’s engagement in HIV issues
more generally was found to be a strong determinant of
male support for CTX-p adherence. These findings add to
the literature around importance of male involvement for
PMTCT and provide an explanation of previous research
findings that showed an increase in uptake of PMTCT ser-
vices with couples testing and counselling [18–21]. Cou-
ples counselling improves the couple’s joint understanding
of HIV and facilitates acceptance of HIV status and the
family’s engagement in HIV treatment and prevention.
Importantly, there was suggestion that men who had not
received education/counselling thought HIV was emascu-
lating, a finding that has been reported in other studies in
Zimbabwe [22, 23]. It is clearly important to find ways to
make couples testing and counselling acceptable to
both parties. Education/messaging that emphasises how
HIV testing can help a man achieve his ‘manly’ roles
may be beneficial, e.g. accessing treatment after testing
HIV positive will help maintain the man’s health and
enable continued participation in masculine roles like
providing for the family.
The fear of stigma was an important factor that lim-
ited women’s ability to give medicine at home or to col-
lect prescription refills from the clinic. Of importance is
the reminder that stigma also exists within marital rela-
tionships, hence the importance of stigma-reduction in-
terventions cannot be overestimated. In addition to
interventions to reduce stigma more generally, it may be
worth considering if any small changes at the clinic
could reduce the stigma associated with pharmacy refill-
for example integration of services as described below.
Stigma interventions have been classified into four cat-
egories: 1) informational approaches to give information
on HIV disease, transmission and methods of reducing
risk of acquisition, e.g. through mass media, educational
lectures etc; 2) skill building, where potential perpetra-
tors of stigma are given skills of how to interact with
HIV positive people, 3) counselling/support to help
HIV positive individuals to cope with the disease, e.g.
in support groups, and 4) testimonials from people liv-
ing with HIV [24, 25]. Many stigma-reduction activities
are already going on in Zimbabwe, e.g. mass media
campaigns, teaching about HIV in schools, and through
the National Behaviour Change Programme, but more
still needs to be done to achieve communities with low
stigma levels. Stigma reduction is particularly important
for PMTCT programs: mathematical modelling esti-
mates that failure to access PMTCT services as a result
of stigma may account for more than half (53 %) of all
perinatal HIV transmissions, and that scale-up of
stigma reduction interventions has the potential to
avert 33 % of vertical infections [26, 27].
The health care system was seen to play an important
role in adherence—stock-outs of cotrimoxazole resulted
in many missed CTX-p doses. Findings in the larger study
indicated that there was more than enough stock of cotri-
moxazole nationally, but that logistic and training chal-
lenges interrupted the supply chain. Training local clinic
staff on supply chain management will alleviate these chal-
lenges. The long waiting times at the clinic were also re-
ported to be problematic, particularly since the mothers
had to wait separately for their own HIV care. Integration
of mother/baby HIV care might help reduce this burden
on mothers. Still on the subject of integration, although
the clinic has taken steps to prevent HIV disclosure by in-
tegrating HIV services within the general chronic diseases
clinic, many people still perceive the integrated unit as an
HIV clinic, which limits women’s ability to freely collect
prescription refills for their babies. Integration of all ser-
vices into the general outpatient clinic might be one way
of solving this challenge.
Limitations
The qualitative study was conducted in a small group
of women in Mbare. Although the findings were
insightful and consistent across participant accounts,
they cannot be generalised to the whole Zimbabwean
population. Information on husband/partner attitudes
towards CTX-p adherence was obtained from the
interviewed women, not the husbands themselves.
Conclusions
The study highlights that adherence knowledge and desire
to protect one’s child from HIV is insufficient to overcome
the familial and structural barriers to maintaining CTX-p.
Improving adherence among HEI will require interven-
tions to improve male engagement with HIV issues and to
increase acceptance of couples counselling and testing, re-
duce HIV stigma in communities and ensure continuous
supply of drugs.
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